Actively Recruiting
Composite Tissue Allotransplantation of the Face: Anatomical and Functional Evaluation
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2026-05-13
5
Participants Needed
1
Research Sites
891 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In hindsight, the first "face graft" raises the fundamental problem of composite tissue allotransplantation (hand, larynx, abdominal wall, etc.) with the addition of specific technical and philosophical problems. By proposing a prospective study concerning five new patients over the next three years, in the light of this first experience, the authors would like to confirm the surgical feasibility of this type of procedure, possibly extending it to other parts of the face (lateral third) and, like English and American teams, considering the possibility of total facial surface reconstruction. In parallel, and while complying with the usual immunosuppression procedures, the deliberate choice of creating a microchimerism by the infusion of bone marrow stem cells (the origin and quantity of which will need to be determined) will be reaffirmed, in order to improve mucocutaneous tissue tolerance, while confirming the safety of this type of approach. Five new cases will also provide observations for the many new fields of research developing around composite tissue transplants (neurophysiology, skin histopathology, psychiatry, haematology, immunology, etc.).
CONDITIONS
Official Title
Composite Tissue Allotransplantation of the Face: Anatomical and Functional Evaluation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with loss of unrepairable substance by conventional techniques shreds, at the front
You will not qualify if you...
- Facial lesions repaired by conventional reconstructive surgery techniques
- History of malignancy in remission for less than 5 years
- Malignant neoplasm undergoing changes
- Severe psychiatric history
- Patients above a score of 2 on the scale of the ASA (American Society of Anesthesiology)
- Patients above a grade 1 in the classification NYHA ( New York Heart Association )
- Insufficient renal function with creatinine clearance less than 70 mL/min or presence of proteinuria
- Severe hypertension
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Amiens
Amiens, France, 80054
Actively Recruiting
Research Team
B
Bernard DEVAUCHELLE, Md, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here